Jamie Larsen, PA
Payments from drug & device makers
Across 71 payments — averaging $43.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Ferring Pharmaceuticals Inc.$188
- Astellas Pharma US Inc$162
- Progenics Pharmaceuticals, Inc.$107
- AbbVie$103
- Coloplast$98
- plus $584 from 18 others
What the payments were for
- Travel & lodging$1,49949%
- Food & beverage$1,47548%
- Education$1003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 14 | $1,830 |
| Ferring Pharmaceuticals Inc. | 9 | $188 |
| Astellas Pharma US Inc | 4 | $162 |
| Progenics Pharmaceuticals, Inc. | 4 | $107 |
| AbbVie(2 entities) | 5 | $103 |
| Coloplast | 5 | $98 |
| Pfizer | 4 | $89 |
| Dendreon Pharmaceuticals LLC | 3 | $67 |
| Tolmar, Inc. | 2 | $53 |
| Urogen Pharma, Inc. | 3 | $47 |
| Millicent US Inc | 2 | $39 |
| Endo Pharmaceuticals Inc. | 2 | $36 |
| Endo USA, Inc. | 2 | $36 |
| Exeltis, USA Inc. | 2 | $29 |
| Teleflex LLC | 1 | $24 |
| Bayer | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Antares Pharma, Inc. | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Blue Earth Diagnostics | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| Organon | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,074 in reported general payments places this provider in the 75th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 58 | $37,354 |
| EliquisApixaban | 46 | $28,208 |
| MyrbetriqMirabegron | 44 | $27,944 |
| XareltoRivaroxaban | 20 | $13,391 |
| JanuviaSitagliptin Phosphate | 14 | $7,847 |
| Methenamine Hippurate | 96 | $6,421 |
| Solifenacin Succinate | 76 | $2,321 |
| Atorvastatin Calcium | 115 | $2,290 |
| Atomoxetine Hcl | 12 | $2,061 |
| Pantoprazole Sodium | 87 | $2,052 |
| Estradiol | 23 | $1,744 |
| Donepezil Hcl | 82 | $1,603 |
| Tamsulosin Hcl | 119 | $1,603 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 15 | $1,493 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $1,432 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $24 | $37,35458 claims |
| PfizerEliquis | $89 | $28,20846 claims |
| Astellas Pharma US IncMyrbetriq | $162 | $27,94444 claims |
| Johnson & JohnsonXarelto | $18 | $13,39120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 748 medical providers in Arizona.
Other medical in Mesa
- Anngela EdkinsMesa$16K
- Tasha MackMesa$14K
- Dana HoffmanMesa$14K
- Laurie PetersonMesa$12K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.